683 Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

683 Capital Management’s Portfolio MLTX Stock Details MLTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Hold
2022 Q2	–	Sell
2022 Q1	$7.9M	Buy
2021 Q4	$5.84M	Buy
2021 Q3	$1.49M	Hold
2021 Q2	$1.55M	Hold
2021 Q1	$1.53M	Hold
2020 Q4	$1.71M	Buy